|
Subscribe to our e-pubs!
You're receiving this email because of your relationship with the Maryland Department of Business and Economic Development. If you no longer wish to receive our emails, [~SubPref~]update your preferences[~EndSubPref~]. |
F E B R U A R Y 2 1, 2 0 1 2
|
 |
Xceleron lands $2.4M, consolidates in Germantown
Learn more
|
 |
BrainScope tapped for State, DOD funding
Learn more
|
 |
MD biotechs use stem cells to treat diabetes, depression
Learn more
| |
|
|
|
|
Opening Doors to Careers in ScienceDr. Timothy Fawcett looks at his job as Director of the BioTechnical Institute of Maryland as the best of both worlds. Joining the Institute in 2001, Dr. Fawcett teaches professional scientists the latest lab techniques, while at the same time helping to open doors for promising students who may not have considered a career in science. Leading the BioSciConcepts workshop program, Dr. Fawcett’s mentors entry-level biotechnicians to meet the demands of Maryland’s rapidly growing biotech life sciences industry. Recently, Life Technologies, a global biotech company with operations in Maryland, named Fawcett as their Cell Culture Hero of the Month.
|
|
|
|
MD Biotechs Advance Diabetes, Depression Treatments
Two Maryland biotech companies are moving forward in efforts to use stem cell treatments for depression and diabetes. Rockville-based Neuralstem received a regulatory nod to advance to phase 1b in its ongoing clinical trial of stem cell treatment for major depressive disorder. Osiris Therapeutics in Columbia reported positive results from a phase 2 clinical trial of its stem cell therapy in patients with newly-diagnosed type 1 diabetes.
|
|
|
|
Xceleron Lands $2.4M, Consolidates in Germantown
Xceleron, a leader in accelerating early drug development secured $2.4 million from investors Albion Ventures and Solon to consolidate the company’s operations to its custom-built facility in Germantown. The company expects to be fully operational in their new space next month and plans to hire additional staff. The facility will be equipped with the latest LC-MS/MS technology, creating the first lab of its kind in which all forms of microtracer and microdose investigations can be conducted in one custom-built facility. |
|
|
|
Cancer-fighting Innovation at UMB BioPark
Ablitech, a biotechnology company developing a gene therapy product that blocks cell division of pancreatic and balder cancer cells, has joined more than 20 innovative companies at the UMB BioPark. Relocating from Mississipi, the company is seeking venture funding and biotechnology partners to advance its patented product, Versadel, a polymer-based product that targets cancer cells, while eluding the body’s immune defenses.
|
|
|
|
Smartphone App Revolutionizes Diabetes Management
What was once a complicated process of managing diabetes is now just a phone click away. Last month, Bethesda-based Telcare introduced the industry’s first FDA-cleared wireless glucose meter. The meter sends results immediately to a private online database where patients, doctors and family members can view the results on a smartphone. The world’s first iPhone app automatically synchronizes with the wireless glucose meter. The MyTelcare Diabetes Pal is now available for free on the Apple App Store. |
|
|
|
Hagerstown Incubator to Graduate First Biotech
This spring, the Technical Innovation Center at Hagerstown Community College graduates its first biotech company from business incubator to commercial space. Tox Path Specialists began operations in May 2008 and has created 17 new jobs for Washington County biotech professionals. The company specializes in toxicological pathology consulting and technical expertise as it relates to the discovery and development of novel human and animal pharmaceuticals.
|
|
|
|
STEM Girls Mentoring Program Expands to MD
Applications The Maryland Biotechnology Center is sponsoring the new STEM Girls in Technology Mentor-Protege Program. It is designed to engage, educate, and inspire high school students of the vast career opportunities available to women in the fields of science, technology, engineering and math. MBC Executive Director Dr. Judy Britz will lead one of the information sessions held on March 1st at the Maryland Biotechnology Center’s Rockville location in the Shady Grove Innovation Center. For more information contact Mary Ann Glueckert at masglueckert@verizon.net or 703-582-3713.
|
|
|
|
|
